# A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

> **NCT03150602** · PHASE4 · UNKNOWN · sponsor: **Taiwan Mundipharma Pharmaceuticals Ltd.** · enrollment: 22 (estimated)

## Conditions studied

- Peripheral T Cell Lymphoma
- Progression, Disease

## Interventions

- **DRUG:** Pralatrexate

## Key facts

- **NCT ID:** NCT03150602
- **Lead sponsor:** Taiwan Mundipharma Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08-30
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2017-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03150602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03150602, "A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03150602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*